-
1
-
-
0037082199
-
The emerging importance of predictive ADME simulation in drug discovery
-
Beresford AP, Selick HE, Tarbit MH. The emerging importance of predictive ADME simulation in drug discovery. Drug Discov Today 2002;7(2):109-116
-
(2002)
Drug Discov Today
, vol.7
, Issue.2
, pp. 109-116
-
-
Beresford, A.P.1
Selick, H.E.2
Tarbit, M.H.3
-
2
-
-
35548954739
-
Improving early drug discovery through ADME modelling: An overview
-
Wishart DS. Improving early drug discovery through ADME modelling: an overview. Drugs R D 2007;8(6):349-362
-
(2007)
Drugs R D
, vol.8
, Issue.6
, pp. 349-362
-
-
Wishart, D.S.1
-
3
-
-
6444234760
-
The role of the medicinal chemist in drug discovery - Then and now
-
Lombardino JG, Lowe JA III. The role of the medicinal chemist in drug discovery-then and now. Nat Rev 2004;3(10):853-862
-
(2004)
Nat Rev
, vol.3
, Issue.10
, pp. 853-862
-
-
Lombardino, J.G.1
Lowe III, J.A.2
-
4
-
-
0042330313
-
ADME-Tox in drug discovery: Integration of experimental and computational technologies
-
Yu H, Adedoyin A. ADME-Tox in drug discovery: integration of experimental and computational technologies. Drug Discov Today 2003;8(18):852-861
-
(2003)
Drug Discov Today
, vol.8
, Issue.18
, pp. 852-861
-
-
Yu, H.1
Adedoyin, A.2
-
5
-
-
0037376928
-
Pharmaceutical profiling in drug discovery
-
Kerns EH, Di L. Pharmaceutical profiling in drug discovery. Drug Discov Today 2003;8(7):316-323
-
(2003)
Drug Discov Today
, vol.8
, Issue.7
, pp. 316-323
-
-
Kerns, E.H.1
Di, L.2
-
6
-
-
0035468033
-
Physicochemical profiling (solubility, permeability and charge state)
-
Avdeef A. Physicochemical profiling (solubility, permeability and charge state). Curr Top Med Chem 2001;1(4):277-351
-
(2001)
Curr Top Med Chem
, vol.1
, Issue.4
, pp. 277-351
-
-
Avdeef, A.1
-
7
-
-
0037413569
-
Surface descriptors for protein-ligand affinity prediction
-
Zamora I, Oprea T, Cruciani G, et al. Surface descriptors for protein-ligand affinity prediction. J Med Chem 2003;46(1):25-33
-
(2003)
J Med Chem
, vol.46
, Issue.1
, pp. 25-33
-
-
Zamora, I.1
Oprea, T.2
Cruciani, G.3
-
8
-
-
22244488749
-
Oral delivery of peptide drugs - Barriers and developments
-
Hamman JH, Enslin GM, Kotze AF. Oral delivery of peptide drugs-Barriers and developments. Biodrugs 2005;19(3):165-177
-
(2005)
Biodrugs
, vol.19
, Issue.3
, pp. 165-177
-
-
Hamman, J.H.1
Enslin, G.M.2
Kotze, A.F.3
-
9
-
-
0025989573
-
Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro
-
Samanen J, Ali F, Romoff T, et al. Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro. J Med Chem 1991;34(10):3114-3125
-
(1991)
J Med Chem
, vol.34
, Issue.10
, pp. 3114-3125
-
-
Samanen, J.1
Ali, F.2
Romoff, T.3
-
10
-
-
39749193898
-
Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity
-
Hess S, Linde Y, Ovadia O, et al. Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity. J Med Chem 2008;51(4):1026-1034
-
(2008)
J Med Chem
, vol.51
, Issue.4
, pp. 1026-1034
-
-
Hess, S.1
Linde, Y.2
Ovadia, O.3
-
11
-
-
0020163940
-
Conformation and biological activity of cyclic peptides
-
Kessler H. Conformation and biological activity of cyclic peptides. Angew Chem Int Ed Engl 1982;21(7):512-523
-
(1982)
Angew Chem Int Ed Engl
, vol.21
, Issue.7
, pp. 512-523
-
-
Kessler, H.1
-
12
-
-
0015515460
-
Preliminary observations on the mechanism of action of somatostatin, a hypothalamic factor inhibiting the secretion of growth hormone
-
Vale W, Brazeau P, Grant G, et al. Preliminary observations on the mechanism of action of somatostatin, a hypothalamic factor inhibiting the secretion of growth hormone. C R Acad Sci Hebd Seances Acad Sci D 1972;275(25):2913-2916
-
(1972)
C R Acad Sci Hebd Seances Acad Sci D
, vol.275
, Issue.25
, pp. 2913-2916
-
-
Vale, W.1
Brazeau, P.2
Grant, G.3
-
13
-
-
0346328229
-
Opportunities in somatostatin research: Biological, chemical and therapeutic aspects
-
Weckbecker G, Lewis I, Albert R, et al. Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat Rev Drug Discov 2003;2(12):999-1017
-
(2003)
Nat Rev Drug Discov
, vol.2
, Issue.12
, pp. 999-1017
-
-
Weckbecker, G.1
Lewis, I.2
Albert, R.3
-
14
-
-
0029114410
-
Molecular biology of somatostatin receptors
-
Reisine T, Bell GI. Molecular biology of somatostatin receptors. Endocr Rev 1995;16(4):427-442
-
(1995)
Endocr Rev
, vol.16
, Issue.4
, pp. 427-442
-
-
Reisine, T.1
Bell, G.I.2
-
15
-
-
2442701779
-
Somatostatin receptor subtypes: Basic pharmacology and tissue distribution
-
Corleto VD, Nasoni S, Panzuto E, et al. Somatostatin receptor subtypes: basic pharmacology and tissue distribution. Dig Liver Dis 2004;36:S8-16
-
(2004)
Dig Liver Dis
, vol.36
-
-
Corleto, V.D.1
Nasoni, S.2
Panzuto, E.3
-
16
-
-
0031610470
-
Discovery and development of somatostatin agonists
-
Borchardt RTRMF, Sawyer TK, Smith PL, editors, Plenum Press, Case Histories NY
-
Marbach PB, Bodmer W, Briner D, et al. Discovery and development of somatostatin agonists. In: Borchardt RTRMF, Sawyer TK, Smith PL, editors, Integration of pharmaceutical discovery and development. Plenum Press, Case Histories NY; 1998. p. 183-209
-
(1998)
Integration of Pharmaceutical Discovery and Development
, pp. 183-209
-
-
Marbach, P.B.1
Bodmer, W.2
Briner, D.3
-
17
-
-
0028605847
-
Differential expression of five somatostatin receptor subtypes, SSTR1-5, in the CNS and peripheral tissue
-
Raulf F, Perez J, Hoyer D, et al. Differential expression of five somatostatin receptor subtypes, SSTR1-5, in the CNS and peripheral tissue. Digestion 1994;55(Suppl 3):46-53
-
(1994)
Digestion
, vol.55
, Issue.SUPPL. 3
, pp. 46-53
-
-
Raulf, F.1
Perez, J.2
Hoyer, D.3
-
18
-
-
0028955742
-
Classification and nomenclature of somatostatin receptors
-
Hoyer D, Bell GI, Berelowitz M, et al. Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci 1995;16(3):86-88
-
(1995)
Trends Pharmacol Sci
, vol.16
, Issue.3
, pp. 86-88
-
-
Hoyer, D.1
Bell, G.I.2
Berelowitz, M.3
-
20
-
-
85011465009
-
Cell specific expression of the sst2A and sst5 somatostatin receptors in the rat anterior pituitary
-
Mezey E, Hunyady B, Mitra S, et al. Cell specific expression of the sst2A and sst5 somatostatin receptors in the rat anterior pituitary. Endocrinology 1998;139(1):414-419
-
(1998)
Endocrinology
, vol.139
, Issue.1
, pp. 414-419
-
-
Mezey, E.1
Hunyady, B.2
Mitra, S.3
-
21
-
-
0032908805
-
Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: A quantitative double-label immunohistochemical analysis
-
Kumar U, Sasi R, Suresh S, et al. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. Diabetes 1999;48(1):77-85
-
(1999)
Diabetes
, vol.48
, Issue.1
, pp. 77-85
-
-
Kumar, U.1
Sasi, R.2
Suresh, S.3
-
22
-
-
0033304716
-
Colocalization of somatostatin receptor sst5 and insulin in rat pancreatic beta-cells
-
Mitra SW, Mezey E, Hunyady B, et al. Colocalization of somatostatin receptor sst5 and insulin in rat pancreatic beta-cells. Endocrinology 1999;140(8):3790-3796
-
(1999)
Endocrinology
, vol.140
, Issue.8
, pp. 3790-3796
-
-
Mitra, S.W.1
Mezey, E.2
Hunyady, B.3
-
23
-
-
0024213731
-
Oncological applications of somatostatin analogues
-
Schally AV. Oncological applications of somatostatin analogues. Cancer Res 1988;48(24 Pt 1):6977-6985
-
(1988)
Cancer Res
, vol.48
, Issue.24 PART 1
, pp. 6977-6985
-
-
Schally, A.V.1
-
24
-
-
0035078132
-
Somatostatin analogs for cancer treatment and diagnosis: An overview
-
Scarpignato C, Pelosini I. Somatostatin analogs for cancer treatment and diagnosis: an overview. Chemotherapy 2001;47(Suppl 2):1-29
-
(2001)
Chemotherapy
, vol.47
, Issue.SUPPL. 2
, pp. 1-29
-
-
Scarpignato, C.1
Pelosini, I.2
-
25
-
-
0031941299
-
Mechanisms of antineoplastic action of somatostatin analogs
-
Pollak MN, Schally AV. Mechanisms of antineoplastic action of somatostatin analogs. Proc Soc Exp Biol Med 1998;217(2):143-152
-
(1998)
Proc Soc Exp Biol Med
, vol.217
, Issue.2
, pp. 143-152
-
-
Pollak, M.N.1
Schally, A.V.2
-
26
-
-
0035084694
-
Antiproliferative effect of somatostatin and analogs
-
Bousquet C, Puente E, Buscail L, et al. Antiproliferative effect of somatostatin and analogs. Chemotherapy 2001;47(Suppl 2):30-39
-
(2001)
Chemotherapy
, vol.47
, Issue.SUPPL. 2
, pp. 30-39
-
-
Bousquet, C.1
Puente, E.2
Buscail, L.3
-
27
-
-
6044276093
-
Future aspects of somatostatin-receptor-mediated therapy
-
Oberg K. Future aspects of somatostatin-receptor-mediated therapy. Neuroendocrinology 2004;80(Suppl 1):57-61
-
(2004)
Neuroendocrinology
, vol.80
, Issue.SUPPL. 1
, pp. 57-61
-
-
Oberg, K.1
-
28
-
-
0020669339
-
In vivo and in vitro plasma disappearance and metabolism of somatostatin-28 and somatostatin-14 in the rat
-
Patel YC, Wheatley T. In vivo and in vitro plasma disappearance and metabolism of somatostatin-28 and somatostatin-14 in the rat. Endocrinology 1983;112(1):220-225
-
(1983)
Endocrinology
, vol.112
, Issue.1
, pp. 220-225
-
-
Patel, Y.C.1
Wheatley, T.2
-
29
-
-
70350324543
-
Efficacy of long-term lanreotide treatment in patients with acromegaly
-
Toledano Y, Rot L, Greenman Y, et al. Efficacy of long-term lanreotide treatment in patients with acromegaly. Pituitary 2009;12(4):285-293
-
(2009)
Pituitary
, vol.12
, Issue.4
, pp. 285-293
-
-
Toledano, Y.1
Rot, L.2
Greenman, Y.3
-
30
-
-
0007296407
-
Synthesis and biological-activity of highly potent octapeptide analogs of somatostatin
-
Cai RZ, Szoke B, Lu R, et al. Synthesis and biological-activity of highly potent octapeptide analogs of somatostatin. PNAS 1986;83(6):1896-1900
-
(1986)
PNAS
, vol.83
, Issue.6
, pp. 1896-1900
-
-
Cai, R.Z.1
Szoke, B.2
Lu, R.3
-
31
-
-
77953701411
-
Receptor gene family -subtype selectivity for ligand binding
-
Srikant CB, editor, Klower Academic Publishers, Boston
-
Hannon JPBCW, Hoyer G, Somatostatin D. Receptor gene family -subtype selectivity for ligand binding. In: Srikant CB, editor, Somatostatin. Klower Academic Publishers, Boston; 2004. p. 87
-
(2004)
Somatostatin
, pp. 87
-
-
Jpbcw, H.1
Hoyer, G.2
Somatostatin, D.3
-
32
-
-
0028157119
-
Relative potencies of the somatostatin analogs octreotide, BIM-23014, and RC-160 on the inhibition of hormone release by cultured human endocrine tumor cells and normal rat anterior pituitary cells
-
Hofland LJ, van Koetsveld PM, Waaijers M, et al. Relative potencies of the somatostatin analogs octreotide, BIM-23014, and RC-160 on the inhibition of hormone release by cultured human endocrine tumor cells and normal rat anterior pituitary cells. Endocrinology 1994;134(1):301-306
-
(1994)
Endocrinology
, vol.134
, Issue.1
, pp. 301-306
-
-
Hofland, L.J.1
Van Koetsveld, P.M.2
Waaijers, M.3
-
33
-
-
0030690974
-
Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors
-
Shimon I, Yan X, Taylor JE, et al. Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors. J Clin Invest 1997;100(9):2386-2392
-
(1997)
J Clin Invest
, vol.100
, Issue.9
, pp. 2386-2392
-
-
Shimon, I.1
Yan, X.2
Taylor, J.E.3
-
34
-
-
17744364678
-
Novel long-acting somatostatin analog with endocrine selectivity: Potent suppression of growth hormone but not of insulin
-
Afargan M, Janson ET, Gelerman G, et al. Novel long-acting somatostatin analog with endocrine selectivity: potent suppression of growth hormone but not of insulin. Endocrinology 2001;142(1):477-486
-
(2001)
Endocrinology
, vol.142
, Issue.1
, pp. 477-486
-
-
Afargan, M.1
Janson, E.T.2
Gelerman, G.3
-
35
-
-
0029802059
-
Drug-induced disorders of glucose metabolism. Mechanisms and management
-
Chan JC, Cockram CS, Critchley JA. Drug-induced disorders of glucose metabolism. Mechanisms and management. Drug Saf 1996;15(2):135-157
-
(1996)
Drug Saf
, vol.15
, Issue.2
, pp. 135-157
-
-
Chan, J.C.1
Cockram, C.S.2
Critchley, J.A.3
-
36
-
-
0024989834
-
Treatment with a somatostatin analog decreases pancreatic B-cell and whole body sensitivity to glucose
-
Kahn SE, Klaff LJ, Schwartz MW, et al. Treatment with a somatostatin analog decreases pancreatic B-cell and whole body sensitivity to glucose. J Clin Endocrinol Metab 1990;71(4):994-1002
-
(1990)
J Clin Endocrinol Metab
, vol.71
, Issue.4
, pp. 994-1002
-
-
Kahn, S.E.1
Klaff, L.J.2
Schwartz, M.W.3
-
37
-
-
34547607571
-
Use of octreotide acetate to prevent rebound hypoglycaemia in sulfonylurea overdose
-
Hassan Z, Wright J. Use of octreotide acetate to prevent rebound hypoglycaemia in sulfonylurea overdose. Emerg Med J 2007;24(8):580-581
-
(2007)
Emerg Med J
, vol.24
, Issue.8
, pp. 580-581
-
-
Hassan, Z.1
Wright, J.2
-
38
-
-
0034874242
-
Intestinal absorption of octreotide using trimethyl chitosan chloride: Studies in pigs
-
Thanou M, Verhoef JC, Verheijden JHM, et al. Intestinal absorption of octreotide using trimethyl chitosan chloride: studies in pigs. Pharm Res 2001;18(6):823-828
-
(2001)
Pharm Res
, vol.18
, Issue.6
, pp. 823-828
-
-
Thanou, M.1
Verhoef, J.C.2
Jhm, V.3
-
39
-
-
0036203977
-
Inhibitory effects of octreotide on luminal cholecystokinin-releasing factor, plasma cholecystokinin, and pancreatic secretion in conscious rats
-
Miyasaka K, Masuda M, Kanai S, et al. Inhibitory effects of octreotide on luminal cholecystokinin-releasing factor, plasma cholecystokinin, and pancreatic secretion in conscious rats. Pancreas 2002;24(3):269-275
-
(2002)
Pancreas
, vol.24
, Issue.3
, pp. 269-275
-
-
Miyasaka, K.1
Masuda, M.2
Kanai, S.3
-
40
-
-
43549108318
-
Selective agonism in somatostatin receptor signaling and regulation
-
Schonbrunn A. Selective agonism in somatostatin receptor signaling and regulation. Mol Cell Endocrinol 2008;286(1-2):35-39
-
(2008)
Mol Cell Endocrinol
, vol.286
, Issue.1-2
, pp. 35-39
-
-
Schonbrunn, A.1
-
41
-
-
34249035476
-
Novel insights in somatostatin receptor physiology
-
Tulipano G, Schulz S. Novel insights in somatostatin receptor physiology. Eur J Endocrinol 2007;156(Suppl 1):S3-11
-
(2007)
Eur J Endocrinol
, vol.156
, Issue.SUPPL. 1
-
-
Tulipano, G.1
Schulz, S.2
-
42
-
-
35649005900
-
Vasculoprotective effects of somatostatin receptor subtypes
-
Tigerstedt NM, Aavik E, Aavik S, et al. Vasculoprotective effects of somatostatin receptor subtypes. Mol Cell Endocrinol 2007;279(1-2):34-38
-
(2007)
Mol Cell Endocrinol
, vol.279
, Issue.1-2
, pp. 34-38
-
-
Tigerstedt, N.M.1
Aavik, E.2
Aavik, S.3
-
43
-
-
13944277784
-
Somatostatin analogs - From new molecules to new applications
-
Pawlikowski M, Melen-Mucha G. Somatostatin analogs- from new molecules to new applications. Curr Opin Pharmacol 2004;4(6):608-613
-
(2004)
Curr Opin Pharmacol
, vol.4
, Issue.6
, pp. 608-613
-
-
Pawlikowski, M.1
Melen-Mucha, G.2
-
44
-
-
33751001270
-
Rationale for the use of somatostatin analogs as antitumor agents
-
Susini C, Buscail L. Rationale for the use of somatostatin analogs as antitumor agents. Ann Oncol 2006;17(12):1733-1742
-
(2006)
Ann Oncol
, vol.17
, Issue.12
, pp. 1733-1742
-
-
Susini, C.1
Buscail, L.2
-
45
-
-
3442880408
-
Differential expression of somatostatin receptor subtypes in hepatocellular carcinomas
-
Blaker M, Schmitz M, Gocht A, et al. Differential expression of somatostatin receptor subtypes in hepatocellular carcinomas. J Hepatol 2004;41(1):112-118
-
(2004)
J Hepatol
, vol.41
, Issue.1
, pp. 112-118
-
-
Blaker, M.1
Schmitz, M.2
Gocht, A.3
-
46
-
-
57349195981
-
Peptide-based probes for cancer imaging
-
Reubi JC, Maecke HR. Peptide-based probes for cancer imaging. J Nucl Med 2008;49(11):1735-1738
-
(2008)
J Nucl Med
, vol.49
, Issue.11
, pp. 1735-1738
-
-
Reubi, J.C.1
Maecke, H.R.2
-
47
-
-
0027513823
-
Effect of octreotide on gall stone prevalence and gall-bladder motility in acromegaly
-
Catnach SM, Anderson JV, Fairclough PD, et al. Effect of octreotide on gall stone prevalence and gall-bladder motility in acromegaly. Gut 1993;34(2):270-273
-
(1993)
Gut
, vol.34
, Issue.2
, pp. 270-273
-
-
Catnach, S.M.1
Anderson, J.V.2
Fairclough, P.D.3
-
48
-
-
0021855165
-
Modified somatostatins as inhibitors of a multispecific transport system for bile acids and phallotoxins in isolated hepatocytes
-
Ziegler K, Frimmer M, Kessler H, et al. Modified somatostatins as inhibitors of a multispecific transport system for bile acids and phallotoxins in isolated hepatocytes. Biochim Biophys Acta 1985;845(1):86-93
-
(1985)
Biochim Biophys Acta
, vol.845
, Issue.1
, pp. 86-93
-
-
Ziegler, K.1
Frimmer, M.2
Kessler, H.3
-
49
-
-
0023698942
-
Azidobenzamido-008, a new photosensitive substrate for the 'multispecific bile acid transporter' of hepatocytes: Evidence for a common transport system for bile acids and cyclosomatostatins in basolateral membranes
-
Ziegler K, Frimmer M, Kessler H, et al. Azidobenzamido-008, a new photosensitive substrate for the 'multispecific bile acid transporter' of hepatocytes: evidence for a common transport system for bile acids and cyclosomatostatins in basolateral membranes. Biochim Biophys Acta 1988;945(2):263-272
-
(1988)
Biochim Biophys Acta
, vol.945
, Issue.2
, pp. 263-272
-
-
Ziegler, K.1
Frimmer, M.2
Kessler, H.3
-
50
-
-
0022809930
-
Conformational prerequisites for the in vitro inhibition of cholate uptake in hepatocytes by cyclic analogs of antamanide and somatostatin
-
Kessler H, Klein M, Muller A, et al. Conformational prerequisites for the in vitro inhibition of cholate uptake in hepatocytes by cyclic analogs of antamanide and somatostatin. Angew Chem Int Ed Engl 1986;25(11):997-999
-
(1986)
Angew Chem Int Ed Engl
, vol.25
, Issue.11
, pp. 997-999
-
-
Kessler, H.1
Klein, M.2
Muller, A.3
-
51
-
-
0030870702
-
Evidence for octreotide subcutaneously in the treatment of acromegaly
-
Liuzzi A, Oppizzi G. Evidence for octreotide subcutaneously in the treatment of acromegaly. J Endocrinol 1997;155(Suppl 1):S61-5
-
(1997)
J Endocrinol
, vol.155
, Issue.SUPPL. 1
-
-
Liuzzi, A.1
Oppizzi, G.2
-
52
-
-
0033535079
-
Potent, orally bioavailable somatostatin agonists: Good absorption achieved by urea backbone cyclization
-
Pasternak A, Pan YP, Marino D, et al. Potent, orally bioavailable somatostatin agonists: Good absorption achieved by urea backbone cyclization. Bioorg Med Chem Lett 1999;9(3):491-496
-
(1999)
Bioorg Med Chem Lett
, vol.9
, Issue.3
, pp. 491-496
-
-
Pasternak, A.1
Pan, Y.P.2
Marino, D.3
-
53
-
-
46749086605
-
Recent progress in the discovery of selective, non-peptide ligands of somatostatin receptors
-
Wolkenberg SE, Thut CJ. Recent progress in the discovery of selective, non-peptide ligands of somatostatin receptors. Curr Opin Drug Discov Dev 2008;11(4):446-457
-
(2008)
Curr Opin Drug Discov Dev
, vol.11
, Issue.4
, pp. 446-457
-
-
Wolkenberg, S.E.1
Thut, C.J.2
-
54
-
-
0032561511
-
Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry
-
Rohrer SP, Birzin ET, Mosley RT, et al. Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science 1998;282(5389):737-740
-
(1998)
Science
, vol.282
, Issue.5389
, pp. 737-740
-
-
Rohrer, S.P.1
Birzin, E.T.2
Mosley, R.T.3
-
55
-
-
65649136518
-
Novel, potent, and radio-iodinatable somatostatin receptor 1 (sst(1)) selective analogues
-
Erchegyi J, Cescato R, Grace CR, et al. Novel, potent, and radio-iodinatable somatostatin receptor 1 (sst(1)) selective analogues. J Med Chem 2009;52(9):2733-2746
-
(2009)
J Med Chem
, vol.52
, Issue.9
, pp. 2733-2746
-
-
Erchegyi, J.1
Cescato, R.2
Grace, C.R.3
-
56
-
-
12344288009
-
Somatostatin receptor 1 selective analogues: 4. Three-dimensional consensus structure by NMR
-
Grace CR, Durrer L, Koerber SC, et al. Somatostatin receptor 1 selective analogues: 4. Three-dimensional consensus structure by NMR. J Med Chem 2005;48(2):523-533
-
(2005)
J Med Chem
, vol.48
, Issue.2
, pp. 523-533
-
-
Grace, C.R.1
Durrer, L.2
Koerber, S.C.3
-
57
-
-
33746674999
-
Novel sst2-selective somatostatin agonists. Three-dimensional consensus structure by NMR
-
Grace CR, Erchegyi J, Koerber SC, et al. Novel sst2-selective somatostatin agonists. Three-dimensional consensus structure by NMR. J Med Chem 2006;49(15):4487-4496
-
(2006)
J Med Chem
, vol.49
, Issue.15
, pp. 4487-4496
-
-
Grace, C.R.1
Erchegyi, J.2
Koerber, S.C.3
-
58
-
-
58149352876
-
Three-dimensional consensus structure of sst2-selective somatostatin (SRIF) antagonists by NMR
-
Grace CR, Erchegyi J, Reubi JC, et al. Three-dimensional consensus structure of sst2-selective somatostatin (SRIF) antagonists by NMR. Biopolymers 2008;89(12):1077-1087
-
(2008)
Biopolymers
, vol.89
, Issue.12
, pp. 1077-1087
-
-
Grace, C.R.1
Erchegyi, J.2
Reubi, J.C.3
-
59
-
-
0345735310
-
Novel sst(4)-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMR
-
Grace CRR, Koerber SC, Erchegyi J, et al. Novel sst(4)-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMR. J Med Chem 2003;46(26):5606-5618
-
(2003)
J Med Chem
, vol.46
, Issue.26
, pp. 5606-5618
-
-
Crr, G.1
Koerber, S.C.2
Erchegyi, J.3
-
60
-
-
33749271351
-
Peptoids - A new approach to the development of pharmaceuticals
-
Kessler H. Peptoids-a new approach to the development of pharmaceuticals. Angew Chem Int Ed Engl 1993;32(4):543-544
-
(1993)
Angew Chem Int Ed Engl
, vol.32
, Issue.4
, pp. 543-544
-
-
Kessler, H.1
-
61
-
-
0034624210
-
Synthesis, biological activities and conformational studies of somatostatin analogs
-
Mattern RH, Moore SB, Tran TA, et al. Synthesis, biological activities and conformational studies of somatostatin analogs. Tetrahedron 2000;56(50):9819-9831
-
(2000)
Tetrahedron
, vol.56
, Issue.50
, pp. 9819-9831
-
-
Mattern, R.H.1
Moore, S.B.2
Tran, T.A.3
-
62
-
-
0028033882
-
Proteolytic studies of homologous peptide and N-substituted glycine peptoid oligomers
-
Miller SM, Simon RJ, Ng S, et al. Proteolytic studies of homologous peptide and N-substituted glycine peptoid oligomers. Bioorg Med Chem Lett 1994;4(22):2657-2662
-
(1994)
Bioorg Med Chem Lett
, vol.4
, Issue.22
, pp. 2657-2662
-
-
Miller, S.M.1
Simon, R.J.2
Ng, S.3
-
63
-
-
0029059507
-
Comparison of the proteolytic susceptibilities of homologous L-amino-acid, D-amino-acid, and N-substituted glycine peptide and peptoid oligomers
-
Miller SM, Simon RJ, Ng S, et al. Comparison of the proteolytic susceptibilities of homologous L-amino-acid, D-amino-acid, and N-substituted glycine peptide and peptoid oligomers. Drug Dev Res 1995;35(1):20-32
-
(1995)
Drug Dev Res
, vol.35
, Issue.1
, pp. 20-32
-
-
Miller, S.M.1
Simon, R.J.2
Ng, S.3
-
64
-
-
0038440483
-
A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential
-
Lewis I, Bauer W, Albert R, et al. A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential. J Med Chem 2003;46(12):2334-2344
-
(2003)
J Med Chem
, vol.46
, Issue.12
, pp. 2334-2344
-
-
Lewis, I.1
Bauer, W.2
Albert, R.3
-
65
-
-
0033851469
-
Conformational and topographical considerations in designing agonist peptidomimetics from peptide leads
-
Hruby VJ, Balse PM. Conformational and topographical considerations in designing agonist peptidomimetics from peptide leads. Curr Med Chem 2000;7(9):945-970
-
(2000)
Curr Med Chem
, vol.7
, Issue.9
, pp. 945-970
-
-
Hruby, V.J.1
Balse, P.M.2
-
66
-
-
68249117645
-
Spatial screening for the identification of the bioactive conformation of integrin ligands
-
Peters T, editor, Berlin, . Springer
-
Weide T, Modlinger A, Kessler H. Spatial screening for the identification of the bioactive conformation of integrin ligands. In: Peters T, editor, Bioactive Conformation I. Springer, Berlin; 2007. p. 1-50
-
(2007)
Bioactive Conformation i
, pp. 1-50
-
-
Weide, T.1
Modlinger, A.2
Kessler, H.3
-
67
-
-
0020363575
-
SMS 201-995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
-
Bauer W, Briner U, Doepfner W, et al. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 1982;31(11):1133-1140
-
(1982)
Life Sci
, vol.31
, Issue.11
, pp. 1133-1140
-
-
Bauer, W.1
Briner, U.2
Doepfner, W.3
-
68
-
-
0019862208
-
A potent cyclic hexapeptide analogue of somatostatin
-
Veber DF, Freidlinger RM, Perlow DS, et al. A potent cyclic hexapeptide analogue of somatostatin. Nature 1981;292(5818):55-58
-
(1981)
Nature
, vol.292
, Issue.5818
, pp. 55-58
-
-
Veber, D.F.1
Freidlinger, R.M.2
Perlow, D.S.3
-
69
-
-
42949155714
-
Ring size in octreotide amide modulates differently agonist versus antagonist binding affinity and selectivity
-
Grace CRR, Erchegyi J, Samant M, et al. Ring size in octreotide amide modulates differently agonist versus antagonist binding affinity and selectivity. J Med Chem 2008;51(9):2676-2681
-
(2008)
J Med Chem
, vol.51
, Issue.9
, pp. 2676-2681
-
-
Crr, G.1
Erchegyi, J.2
Samant, M.3
-
70
-
-
0020845060
-
Peptide conformations 28 Relayed heteronuclear correlation spectroscopy and conformational-analysis of cyclic hexapeptides containing the active sequence of somatostatin
-
Kessler H, Bernd M, Kogler H, et al. Peptide conformations 28. Relayed heteronuclear correlation spectroscopy and conformational-analysis of cyclic hexapeptides containing the active sequence of somatostatin. JACS 1983;105(23):6944-6952
-
(1983)
JACS
, vol.105
, Issue.23
, pp. 6944-6952
-
-
Kessler, H.1
Bernd, M.2
Kogler, H.3
-
71
-
-
0038808747
-
Conformation of cyclic peptides.Principle concepts and the design of selectivity and superactivity in bioactive sequences by 'spatial screening
-
Kessler H, Gratias R, Hessler G, et al. Conformation of cyclic peptides. Principle concepts and the design of selectivity and superactivity in bioactive sequences by 'spatial screening'. Pure Appl Chem 1996;68(6):1201-1205
-
(1996)
Pure Appl Chem
, vol.68
, Issue.6
, pp. 1201-1205
-
-
Kessler, H.1
Gratias, R.2
Hessler, G.3
-
72
-
-
0025880146
-
Arg-Gly-Asp constrained within cyclic pentapeptides - Strong and selective inhibitors of cell-adhesion to vitronectin and laminin fragment-P1
-
Aumailley M, Gurrath M, Muller G, et al. Arg-Gly-Asp constrained within cyclic pentapeptides-strong and selective inhibitors of cell-adhesion to vitronectin and laminin fragment-P1. FEBS Lett 1991;291(1):50-54
-
(1991)
FEBS Lett
, vol.291
, Issue.1
, pp. 50-54
-
-
Aumailley, M.1
Gurrath, M.2
Muller, G.3
-
73
-
-
0030768536
-
Stereoisomeric peptide libraries and peptidomimetics for designing selective inhibitors of the alpha(V)beta(3) integrin for a new cancer therapy
-
Haubner R, Finsinger D, Kessler H. Stereoisomeric peptide libraries and peptidomimetics for designing selective inhibitors of the alpha(V)beta(3) integrin for a new cancer therapy. Angew Chem Int Ed Engl 1997;36(13-14):1375- 1389
-
(1997)
Angew Chem Int Ed Engl
, vol.36
, Issue.13-14
, pp. 1375-1389
-
-
Haubner, R.1
Finsinger, D.2
Kessler, H.3
-
74
-
-
0033549864
-
N-methylated cyclic RGD peptides as highly active and selective alpha(v)beta3) integrin antagonists
-
Dechantsreiter MA, Planker E, Matha B, et al. N-methylated cyclic RGD peptides as highly active and selective alpha(v)beta (3) integrin antagonists. J Med Chem 1999;42(16):3033-3040
-
(1999)
J Med Chem
, vol.42
, Issue.16
, pp. 3033-3040
-
-
Dechantsreiter, M.A.1
Planker, E.2
Matha, B.3
-
75
-
-
0026155124
-
Backbone cyclization: A new method for conferring conformational constraint on peptides
-
Gilon C, Halle D, Chorev M, et al. Backbone cyclization: a new method for conferring conformational constraint on peptides. Biopolymers 1991;31(6):745-750
-
(1991)
Biopolymers
, vol.31
, Issue.6
, pp. 745-750
-
-
Gilon, C.1
Halle, D.2
Chorev, M.3
-
76
-
-
0034888722
-
Facile synthesis of orthogonally protected amino acid building blocks for combinatorial N-backbone cyclic peptide chemistry
-
Gellerman G, Elgavi A, Salitra Y, et al. Facile synthesis of orthogonally protected amino acid building blocks for combinatorial N-backbone cyclic peptide chemistry. J Pept Res 2001;57(4):277-291
-
(2001)
J Pept Res
, vol.57
, Issue.4
, pp. 277-291
-
-
Gellerman, G.1
Elgavi, A.2
Salitra, Y.3
-
77
-
-
0031038621
-
Building units for N-backbone cyclic peptides. 3. Synthesis of protected N (alpha)-(omega-Aminoalkyl)amino acids and N(alpha)-(omega-Carboxyalkyl) amino Acids
-
Muller D, Zeltser I, Bitan G, et al. Building units for N-backbone cyclic peptides. 3. Synthesis of protected N (alpha)-(omega-Aminoalkyl)amino acids and N(alpha)-(omega-Carboxyalkyl) amino Acids. J Org Chem 1997;62(2):411-416
-
(1997)
J Org Chem
, vol.62
, Issue.2
, pp. 411-416
-
-
Muller, D.1
Zeltser, I.2
Bitan, G.3
-
78
-
-
0035718972
-
Synthesis of novel protected Nalpha (omega-thioalkyl) amino acid building units and their incorporation in backbone cyclic disulfide and thioetheric bridged peptides
-
Gazal S, Gellerman G, Glukhov E, et al. Synthesis of novel protected Nalpha (omega-thioalkyl) amino acid building units and their incorporation in backbone cyclic disulfide and thioetheric bridged peptides. J Pept Res 2001;58(6):527-539
-
(2001)
J Pept Res
, vol.58
, Issue.6
, pp. 527-539
-
-
Gazal, S.1
Gellerman, G.2
Glukhov, E.3
-
79
-
-
0033041516
-
In situ generation of Fmoc-amino acid chlorides using bis-(trichloromethyl) carbonate and its utilization for difficult couplings in solid-phase peptide synthesis
-
Falb E, Yechezkel T, Salitra Y, et al. In situ generation of Fmoc-amino acid chlorides using bis-(trichloromethyl) carbonate and its utilization for difficult couplings in solid-phase peptide synthesis. J Pept Res 1999;53(5):507-517
-
(1999)
J Pept Res
, vol.53
, Issue.5
, pp. 507-517
-
-
Falb, E.1
Yechezkel, T.2
Salitra, Y.3
-
80
-
-
0033578941
-
Miniaturized proteins: The backbone cyclic proteinomimetic approach
-
Kasher R, Oren DA, Barda Y, et al. Miniaturized proteins: the backbone cyclic proteinomimetic approach. J Mol Biol 1999;292(2):421-429
-
(1999)
J Mol Biol
, vol.292
, Issue.2
, pp. 421-429
-
-
Kasher, R.1
Oren, D.A.2
Barda, Y.3
-
81
-
-
0029742789
-
Synthesis and biological activity of NK-1 selective, N-backbone cyclic analogs of the C-terminal hexapeptide of substance P
-
Byk G, Halle D, Zeltser I, et al. Synthesis and biological activity of NK-1 selective, N-backbone cyclic analogs of the C-terminal hexapeptide of substance P. J Med Chem 1996;39(16):3174-3178
-
(1996)
J Med Chem
, vol.39
, Issue.16
, pp. 3174-3178
-
-
Byk, G.1
Halle, D.2
Zeltser, I.3
-
82
-
-
37848999397
-
Effect of structural and conformation modifications, including backbone cyclization, of hydrophilic hexapeptides on their intestinal permeability and enzymatic stability
-
Hess S, Ovadia O, Shalev DE, et al. Effect of structural and conformation modifications, including backbone cyclization, of hydrophilic hexapeptides on their intestinal permeability and enzymatic stability. J Med Chem 2007;50(24):6201-6211
-
(2007)
J Med Chem
, vol.50
, Issue.24
, pp. 6201-6211
-
-
Hess, S.1
Ovadia, O.2
Shalev, D.E.3
-
83
-
-
15644375594
-
A backbone-cyclic, receptor 5-selective somatostatin analogue: Synthesis, bioactivity, and nuclear magnetic resonance conformational analysis
-
Gilon C, Huenges M, Matha B, et al. A backbone-cyclic, receptor 5-selective somatostatin analogue: synthesis, bioactivity, and nuclear magnetic resonance conformational analysis. J Med Chem 1998;41(6):919-929
-
(1998)
J Med Chem
, vol.41
, Issue.6
, pp. 919-929
-
-
Gilon, C.1
Huenges, M.2
Matha, B.3
-
84
-
-
18044405028
-
A bicyclic and hsst2 selective somatostatin analogue: Design, synthesis, conformational analysis and binding
-
Falb E, Salitra Y, Yechezkel T, et al. A bicyclic and hsst2 selective somatostatin analogue: design, synthesis, conformational analysis and binding. Bioorg Med Chem 2001;9(12):3255-3264
-
(2001)
Bioorg Med Chem
, vol.9
, Issue.12
, pp. 3255-3264
-
-
Falb, E.1
Salitra, Y.2
Yechezkel, T.3
-
85
-
-
0037061645
-
Human somatostatin receptor specificity of backbone-cyclic analogues containing novel sulfur building units
-
Gazal S, Gelerman G, Ziv O, et al. Human somatostatin receptor specificity of backbone-cyclic analogues containing novel sulfur building units. J Med Chem 2002;45(8):1665-1671
-
(2002)
J Med Chem
, vol.45
, Issue.8
, pp. 1665-1671
-
-
Gazal, S.1
Gelerman, G.2
Ziv, O.3
-
86
-
-
0347999767
-
Synthesis and characterization of octapeptide somatostatin analogues with backbone cyclization: Comparison of different strategies, biological activities and enzymatic stabilities
-
Besser D, Muller B, Kleinwachter P, et al. Synthesis and characterization of octapeptide somatostatin analogues with backbone cyclization: comparison of different strategies, biological activities and enzymatic stabilities. J Prakt Chem 2000;342(6):537-545
-
(2000)
J Prakt Chem
, vol.342
, Issue.6
, pp. 537-545
-
-
Besser, D.1
Muller, B.2
Kleinwachter, P.3
-
87
-
-
0031463595
-
Synthesis and biological evaluation of potent, selective, hexapeptide CCK-A agonist anorectic agents
-
Pierson ME, Comstock JM, Simmons RD, et al. Synthesis and biological evaluation of potent, selective, hexapeptide CCK-A agonist anorectic agents. J Med Chem 1997;40(26):4302-4307
-
(1997)
J Med Chem
, vol.40
, Issue.26
, pp. 4302-4307
-
-
Pierson, M.E.1
Comstock, J.M.2
Simmons, R.D.3
-
88
-
-
0029877665
-
In vitro assessment of oral delivery for hexapeptide endothelin antagonists
-
Stewart BH, Reyner EL, Tse E, et al. In vitro assessment of oral delivery for hexapeptide endothelin antagonists. Life sci 1996;58(12):971-982
-
(1996)
Life Sci
, vol.58
, Issue.12
, pp. 971-982
-
-
Stewart, B.H.1
Reyner, E.L.2
Tse, E.3
-
89
-
-
57349171593
-
N-methylation of peptides: A new perspective in medicinal chemistry
-
Chatterjee J, Gilon C, Hoffman A, et al. N-methylation of peptides: a new perspective in medicinal chemistry. Acc Chem Res 2008;41(10):1331-1342
-
(2008)
Acc Chem Res
, vol.41
, Issue.10
, pp. 1331-1342
-
-
Chatterjee, J.1
Gilon, C.2
Hoffman, A.3
-
90
-
-
0035953312
-
N-Methyl scan of somatostatin octapeptide agonists produces interesting effects on receptor subtype specificity
-
Rajeswaran WG, Hocart SJ, Murphy WA, et al. N-Methyl scan of somatostatin octapeptide agonists produces interesting effects on receptor subtype specificity. J Med Chem 2001;44(9):1416-1421
-
(2001)
J Med Chem
, vol.44
, Issue.9
, pp. 1416-1421
-
-
Rajeswaran, W.G.1
Hocart, S.J.2
Murphy, W.A.3
-
91
-
-
0030936620
-
Site-selective N-methylation of peptides on solid support
-
Miller SC, Scanlan TS. Site-selective N-methylation of peptides on solid support. JACS 1997;119(9):2301-2302
-
(1997)
JACS
, vol.119
, Issue.9
, pp. 2301-2302
-
-
Miller, S.C.1
Scanlan, T.S.2
-
92
-
-
33644799946
-
Optimized selective N-methylation of peptides on solid support
-
Biron E, Chatterjee J, Kessler H. Optimized selective N-methylation of peptides on solid support. J Pept Sci 2006;12(3):213-219
-
(2006)
J Pept Sci
, vol.12
, Issue.3
, pp. 213-219
-
-
Biron, E.1
Chatterjee, J.2
Kessler, H.3
-
93
-
-
0024412409
-
Blood-pressure reduction in hypertensive-diabetic rats by the somatostatin analog Mk-678
-
Hartmann J, Szemplinski M, Chen SL, et al. Blood-pressure reduction in hypertensive-diabetic rats by the somatostatin analog Mk-678. Life Sci 1989;45(3):267-274
-
(1989)
Life Sci
, vol.45
, Issue.3
, pp. 267-274
-
-
Hartmann, J.1
Szemplinski, M.2
Chen, S.L.3
-
94
-
-
41949086504
-
Improving oral bioavailability of peptides by multiple N-methylation: Somatostatin analogues
-
Biron E, Chatterjee J, Ovadia O, et al. Improving oral bioavailability of peptides by multiple N-methylation: somatostatin analogues. Angew Chem Int Ed Engl 2008;47(14):2595-2599
-
(2008)
Angew Chem Int Ed Engl
, vol.47
, Issue.14
, pp. 2595-2599
-
-
Biron, E.1
Chatterjee, J.2
Ovadia, O.3
-
95
-
-
0036282611
-
Somatostatin receptor subtypes 2 and 5 inhibit corticotropin-releasing hormonestimulated adrenocorticotropin secretion from AtT-20 cells
-
Strowski MZ, Dashkevicz MP, Parmar RM, et al. Somatostatin receptor subtypes 2 and 5 inhibit corticotropin-releasing hormonestimulated adrenocorticotropin secretion from AtT-20 cells. Neuroendocrinology 2002;75(6):339-346
-
(2002)
Neuroendocrinology
, vol.75
, Issue.6
, pp. 339-346
-
-
Strowski, M.Z.1
Dashkevicz, M.P.2
Parmar, R.M.3
-
96
-
-
0036216889
-
Characterization of new selective somatostatin receptor subtype-2 (sst2) antagonists BIM-23627 and BIM-23454. Effects of BIM-23627 on GH release in anesthetized male rats after short-term high-dose dexamethasone treatment
-
Tulipano G, Soldi D, Bagnasco M, et al. Characterization of new selective somatostatin receptor subtype-2 (sst2) antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH release in anesthetized male rats after short-term high-dose dexamethasone treatment. Endocrinology 2002;143(4):1218-1224
-
(2002)
Endocrinology
, vol.143
, Issue.4
, pp. 1218-1224
-
-
Tulipano, G.1
Soldi, D.2
Bagnasco, M.3
-
97
-
-
0033600778
-
Nonpeptidyl somatostatin agonists demonstrate that sst2 and sst5 inhibit stimulated growth hormone secretion from rat anterior pituitary cells
-
Parmar RM, Chan WW, Dashkevicz M, et al. Nonpeptidyl somatostatin agonists demonstrate that sst2 and sst5 inhibit stimulated growth hormone secretion from rat anterior pituitary cells. Biochem Biophys Res Commun 1999;263(2):276-280
-
(1999)
Biochem Biophys Res Commun
, vol.263
, Issue.2
, pp. 276-280
-
-
Parmar, R.M.1
Chan, W.W.2
Dashkevicz, M.3
-
98
-
-
33845480306
-
Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues
-
Ludvigsen E, Stridsberg M, Taylor JE, et al. Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues. Regul Pept 2007;138(1):1-9
-
(2007)
Regul Pept
, vol.138
, Issue.1
, pp. 1-9
-
-
Ludvigsen, E.1
Stridsberg, M.2
Taylor, J.E.3
-
99
-
-
66249144426
-
The structure and function of G-protein-coupled receptors
-
Rosenbaum DM, Rasmussen SG, Kobilka BK. The structure and function of G-protein-coupled receptors. Nature 2009;459(7245):356-363
-
(2009)
Nature
, vol.459
, Issue.7245
, pp. 356-363
-
-
Rosenbaum, D.M.1
Rasmussen, S.G.2
Kobilka, B.K.3
-
100
-
-
69249206623
-
G protein-coupled receptor hetero-dimerization: Contribution to pharmacology and function
-
Milligan G. G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function. Br J Pharmacol 2009;158(1):5-14
-
(2009)
Br J Pharmacol
, vol.158
, Issue.1
, pp. 5-14
-
-
Milligan, G.1
-
101
-
-
43749115484
-
Dimerization of G protein-coupled receptors: New avenues for somatostatin receptor signalling, control and functioning
-
Duran-Prado M, Malagon MM, Gracia-Navarro F, et al. Dimerization of G protein-coupled receptors: new avenues for somatostatin receptor signalling, control and functioning. Mol Cell Endocrinol 2008;286(1-2):63-68
-
(2008)
Mol Cell Endocrinol
, vol.286
, Issue.1-2
, pp. 63-68
-
-
Duran-Prado, M.1
Malagon, M.M.2
Gracia-Navarro, F.3
-
102
-
-
0036780743
-
G-protein-coupled receptor oligomerization and its potential for drug discovery
-
George SR, O'Dowd BF, Lee SP. G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat Rev 2002;1(10):808-820
-
(2002)
Nat Rev
, vol.1
, Issue.10
, pp. 808-820
-
-
George, S.R.1
O'Dowd, B.F.2
Lee, S.P.3
-
103
-
-
0035958027
-
Homo- and heterodimerization of somatostatin receptor subtypes - Inactivation of sst(3) receptor function by heterodimerization with sst(2A)
-
Pfeiffer M, Koch T, Schroder H, et al. Homo- and heterodimerization of somatostatin receptor subtypes - Inactivation of sst(3) receptor function by heterodimerization with sst(2A). J Biol Chem 2001;276(17):14027-14036
-
(2001)
J Biol Chem
, vol.276
, Issue.17
, pp. 14027-14036
-
-
Pfeiffer, M.1
Koch, T.2
Schroder, H.3
-
104
-
-
34250019669
-
Industrial applications of solid-phase peptide synthesis - A status report
-
Verlander M. Industrial applications of solid-phase peptide synthesis - A status report. Int J Pept Res Ther 2007;13(1-2):75-82
-
(2007)
Int J Pept Res Ther
, vol.13
, Issue.1-2
, pp. 75-82
-
-
Verlander, M.1
-
105
-
-
66349097253
-
Opportunities and challenges of developing peptide drugs in the pharmaceutical industry
-
Danho W, Swistok J, Khan W, et al. Opportunities and challenges of developing peptide drugs in the pharmaceutical industry. Adv Exp Med Biol 2009;611:467-469
-
(2009)
Adv Exp Med Biol
, vol.611
, pp. 467-469
-
-
Danho, W.1
Swistok, J.2
Khan, W.3
-
106
-
-
84890588610
-
Design of cyclic peptides
-
Jensen K, editor, Wiley & Sons Ltd
-
Demmer O, Frank AO, Kessler H. Design of cyclic peptides. In: Jensen K, editor, Peptide and protein design for biopharmaceutical applications. Wiley & Sons Ltd; 2009. p. 133-176
-
(2009)
Peptide and Protein Design for Biopharmaceutical Applications
, pp. 133-176
-
-
Demmer, O.1
Frank, A.O.2
Kessler, H.3
-
108
-
-
0035289779
-
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
-
Lipinski CA, Lombardo F, Dominy BW, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;46(1-3):3-26
-
(2001)
Adv Drug Deliv Rev
, vol.46
, Issue.1-3
, pp. 3-26
-
-
Lipinski, C.A.1
Lombardo, F.2
Dominy, B.W.3
-
109
-
-
0037030653
-
Molecular properties that influence the oral bioavailability of drug candidates
-
Veber DF, Johnson SR, Cheng HY, et al. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 2002;45(12):2615-2623
-
(2002)
J Med Chem
, vol.45
, Issue.12
, pp. 2615-2623
-
-
Veber, D.F.1
Johnson, S.R.2
Cheng, H.Y.3
-
110
-
-
0025887582
-
Factors influencing the pharmacokinetics of cyclosporine in man
-
Lindholm A. Factors influencing the pharmacokinetics of cyclosporine in man. Ther Drug Monit 1991;13(6):465-477
-
(1991)
Ther Drug Monit
, vol.13
, Issue.6
, pp. 465-477
-
-
Lindholm, A.1
-
111
-
-
0021923153
-
Peptide conformations 31. The conformation of cyclosporin - A in the crystal and in solution
-
Loosli HR, Kessler H, Oschkinat H, et al. Peptide conformations 31. The conformation of cyclosporin-a in the crystal and in solution. Helvetica Chim Acta 1985;68(3):682-704
-
(1985)
Helvetica Chim Acta
, vol.68
, Issue.3
, pp. 682-704
-
-
Loosli, H.R.1
Kessler, H.2
Oschkinat, H.3
-
112
-
-
20844455294
-
Convenient synthesis of N-methylamino acids compatible with Fmoc solid-phase peptide synthesis
-
Biron E, Kessler H. Convenient synthesis of N-methylamino acids compatible with Fmoc solid-phase peptide synthesis. J Org Chem 2005;70(13):5183-5189
-
(2005)
J Org Chem
, vol.70
, Issue.13
, pp. 5183-5189
-
-
Biron, E.1
Kessler, H.2
-
113
-
-
66349097560
-
Highly selective cyclic hexapeptides antagonist of GPIIb-IIIa by multiple N-methylation
-
Chatterjee J, Ovadia O, Zahn G, et al. Highly selective cyclic hexapeptides antagonist of GPIIb-IIIa by multiple N-methylation. Adv Exp Med Biol 2009;611:209-210
-
(2009)
Adv Exp Med Biol
, vol.611
, pp. 209-210
-
-
Chatterjee, J.1
Ovadia, O.2
Zahn, G.3
-
114
-
-
77949761682
-
Novel method for the synthesis of urea backbone cyclic peptides using new Alloc protected glycine building units
-
Hurevich MT-G, Klein Y, Barda S, et al. Novel method for the synthesis of urea backbone cyclic peptides using new Alloc protected glycine building units. J Pept Sci 2010;16(4):178-185
-
(2010)
J Pept Sci
, vol.16
, Issue.4
, pp. 178-185
-
-
Mt-G, H.1
Klein, Y.2
Barda, S.3
-
115
-
-
0036199061
-
Drug design at peptide receptors - Somatostatin receptor ligands
-
Hannon JP, Nunn C, Stolz B, et al. Drug design at peptide receptors - Somatostatin receptor ligands. J Mol Neurosci 2002;18(1-2):15-27
-
(2002)
J Mol Neurosci
, vol.18
, Issue.1-2
, pp. 15-27
-
-
Hannon, J.P.1
Nunn, C.2
Stolz, B.3
-
116
-
-
0028020115
-
Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5)
-
Patel YC, Srikant CB. Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5). Endocrinology 1994;135(6):2814-2817
-
(1994)
Endocrinology
, vol.135
, Issue.6
, pp. 2814-2817
-
-
Patel, Y.C.1
Srikant, C.B.2
|